Edition:
United Kingdom

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

743.70INR
18 May 2018
Change (% chg)

-- (--)
Prev Close
Rs743.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,618,483
52-wk High
Rs1,327.00
52-wk Low
Rs723.65

Latest Key Developments (Source: Significant Developments)

India's Lupin Posts March Quarter Consol Net Loss
Tuesday, 15 May 2018 

May 15 (Reuters) - Lupin Ltd ::MARCH QUARTER CONSOL NET LOSS 7.84 BILLION RUPEES VERSUS PROFIT OF 3.80 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 40.34 BILLION RUPEES VERSUS 42.53 BILLION RUPEES LAST YEAR.SAYS QTRLY EXCEPTIONAL ITEM WAS 14.64 BILLION RUPEES.RECOMMENDED DIVIDEND OF 5 RUPEES PER SHARE.CONSENSUS FORECAST FOR MARCH QUARTER CONSOL PROFIT WAS 3.20 BILLION RUPEES.EXCEPTIONAL ITEM REPRESENTS IMPAIRMENT PROVISION OF 14.64 BILLION RUPEES ON CERTAIN INTANGIBLE ASSETS ACQUIRED AS PART OF GAVIS GROUP ACQUISITION.NEAR-TERM PRIORITIES INCLUDE RESOLUTION OF WARNING LETTER ON GOA AND INDORE UNIT 2.  Full Article

India's Lupin Gets FDA Approval For Generic Temovate Ointment, 0.05 Percent
Monday, 7 May 2018 

May 7 (Reuters) - Lupin Ltd ::GETS FDA APPROVAL FOR GENERIC TEMOVATE OINTMENT, 0.05 PERCENT.TEMOVATE OINTMENT IS INDICATED FOR RELIEF OF INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES.  Full Article

India's Lupin Says Pithampur Unit Cleared By Health Canada
Monday, 2 Apr 2018 

April 2 (Reuters) - Lupin Ltd ::PITHAMPUR UNIT CLEARED BY HEALTH CANADA.SAYS HEALTH CANADA MAINTAINED COMPLIANT RATING FOR UNIT 2 AT PITHAMPUR (INDORE) AND HAS ISSUED A REVISED ‘ESTABLISHMENT LICENSE’.  Full Article

Lupin Launches Generic Clobex Spray, 0.05 Pct In U.S.
Thursday, 29 Mar 2018 

March 29 (Reuters) - Lupin Ltd ::LAUNCHES GENERIC CLOBEX SPRAY, 0.05 PERCENT IN THE US ‍​.SPRAY IS USED FOR TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS AFFECTING UP TO 20 PERCENT BODY SURFACE AREA IN PATIENTS 18 YEARS OF AGE OR OLDER.  Full Article

Lupin Gets FDA Approval For Generic Topicort Topical Spray, 0.25 Pct
Monday, 19 Mar 2018 

March 19 (Reuters) - Lupin Ltd ::SAYS CO RECEIVES FDA APPROVAL FOR GENERIC TOPICORT TOPICAL SPRAY, 0.25 PERCENT.  Full Article

Lupin Signs Agreement With CSIR-NCL And DST
Thursday, 8 Mar 2018 

March 8 (Reuters) - Lupin Ltd ::SIGNS AGREEMENT WITH CSIR-NCL AND DST FOR DEVELOPMENT OF CONTINUOUS MANUFACTURING PROCESS FOR BIOSIMILAR MONOCLONAL ANTIBODY THERAPEUTIC‍​.  Full Article

Lupin Launches Generic Axiron Topical Solution In The U.S.
Monday, 26 Feb 2018 

Feb 26 (Reuters) - Lupin Ltd ::LAUNCHES GENERIC AXIRON TOPICAL SOLUTION IN THE US.  Full Article

Lupin Launches Generic Axirona Topical Solution In U.S.
Monday, 26 Feb 2018 

Feb 26 (Reuters) - Lupin Ltd ::LAUNCHES GENERIC AXIRONÂ TOPICAL SOLUTION IN THE US.  Full Article

Lupin Launches Generic Namenda Xr Capsules In U.S.‍​
Wednesday, 21 Feb 2018 

Feb 21 (Reuters) - Lupin Ltd ::LAUNCHES GENERIC NAMENDA XR CAPSULES IN THE US‍​.SAYS DRUG IS INDICATED FOR TREATMENT OF MODERATE TO SEVERE DEMENTIA OF ALZHEIMER'S TYPE‍​.  Full Article

India's Lupin Gets U.S. ‍FDA Nod For Generic Tamiflu
Wednesday, 21 Feb 2018 

Feb 21 (Reuters) - Lupin Ltd ::GETS U.S. ‍FDA APPROVAL FOR GENERIC TAMIFLU FOR ORAL SUSPENSION​.  Full Article

UPDATE 2-India's Lupin expects U.S. drug pricing pressure to ease in 2019

* U.S. sales fall 21.1 pct; India sales up 14 pct (Adds management comments from conference call)